About Ankerite Pharmaceuticals Private Limited
Data last updated:
Ankerite Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2006PTC031249. Its GSTIN is 09AAFCA7346B1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Kirti Kumar and Sunil Rohatgi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Md 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, India.
As per MCA filings, the company has open charges of ₹2.9 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ankeritesuppliment.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressMd 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ankerite Pharmaceuticals Private Limited
The main business activity of Ankerite Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ankerite Pharmaceuticals Private Limited FY 2025 filings available
Ankerite Pharmaceuticals Private Limited reported revenue of ₹52 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ankerite Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 98% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ankerite Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ankerite Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ankerite Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals has 7 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirti Kumar Also directs: Ankerite Health Care Private Limited | Director | 15 Dec 2008 | 17 Years 10 Months | Current |
| Sunil Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Reetika Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Kiran Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Ishan Arora Also directs: Bhaarat Infradevelopers LLP | Director | 11 Jun 2020 | 6 Years 4 Months | Current |
| Chandrabhan | Director | 11 Jun 2020 | 6 Years 4 Months | Current |
Peer Comparison of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Upaj Polycon Private Limited | ₹91 (FY 2025) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
| Nautilus Pharmaceuticals Private Limited | ₹90 (FY 2025) | •••• | •••• | •••• | Thrissur, Kerala, India | |
| Shreyash Healthcare India Private Limited | ₹80 (FY 2025) | •••• | •••• | -100.0% | •••• | Agra, Uttar Pradesh, India |
| Lakemedel Pharmaceuticals Private Limited | ₹72 (FY 2025) | •••• | •••• | -100.0% | •••• | Ahmedabad, Gujarat, India |
| Reynish Pharmachem Private Limited | ₹66 (FY 2025) | •••• | •••• | -99.0% | •••• | Vadodara, Gujarat, India |
| Ankerite Pharmaceuticals Private Limited this company | ₹52 (FY 2025) | •••• | •••• | -100.0% | •••• | Uttar Pradesh, India |
| Biolife Healthcare ( India ) Private Limited | ₹52 (FY 2016) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| CLS Council of Electrohomoeopathy | ₹45 (FY 2025) | •••• | •••• | •••• | Diva Agason Road, Thane, Maharashtra, India | |
| Marig LD Pharma Private Limited | ₹43 (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Vijjaya Pharmachem Private Limited | ₹37 (FY 2025) | •••• | •••• | 1750.0% | •••• | Vadodara, Gujarat, India |
| Vogaa Life Sciences Private Limited | ₹26 (FY 2021) | •••• | •••• | •••• | Mohammadwadi, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ankerite Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals Private Limited is audited by D S SINHA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D S SINHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ankerite Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ankerite Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2018 | Others | ₹2.9 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Court case (Complaint Cases) | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Ankerite Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ankerite Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals Private Limited has 9 board changes on record since 2006: 8 appointments and 1 cessation. The latest: Sunita Rohtagi ceased to be Director on 22 Nov 2021.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ankerite Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ankerite Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ankerite Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCA7346B1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ankerite Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2006 (20+ years old) and is registered under CIN U24232UP2006PTC031249.
Ankerite Pharmaceuticals has 7 current directors:
- Kirti Kumar - Director
- Sunil Rohatgi - Director
- Reetika Rohatgi - Director
- Kiran Rohatgi - Director
- Ishan Arora - Director
- Chandrabhan - Director
- Karan Kathuria - Director
The GSTIN of Ankerite Pharmaceuticals is 09AAFCA7346B1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ankerite Pharmaceuticals is U24232UP2006PTC031249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankerite Pharmaceuticals has 1 court case on record: 1 filed against it.
Ankerite Pharmaceuticals was incorporated on 23 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ankerite Pharmaceuticals by revenue are Upaj Polycon Private Limited, Nautilus Pharmaceuticals Private Limited, Shreyash Healthcare India Private Limited, Lakemedel Pharmaceuticals Private Limited, Reynish Pharmachem Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sunita Rohtagi ceased to be Director on 22 Nov 2021. Chandrabhan was appointed as Director on 11 Jun 2020. Ishan Arora was appointed as Director on 11 Jun 2020. Ankerite Pharmaceuticals has 9 board changes on record in total.
Ankerite Pharmaceuticals can be reached through the website ankeritesuppliment.com. Its registered office is in Uttar Pradesh, India.
The registered office of Ankerite Pharmaceuticals is at Md 1163 Dayakunjmansarover Lucknow, Uttar Pradesh, India.
Ankerite Pharmaceuticals has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh.